«Back

Class 2 Recall on Ranitidine Oral Solution 30mg/Ml & Ranitidine 150mg Creo Ltd & Tillomed Ltd

Class 2 Recall on Ranitidine Oral Solution 30mg/Ml & Ranitidine 150mg Creo Ltd & Tillomed Ltd

Creo Pharma Limited and Tillomed Laboratories Limited are recalling all unexpired stock of the below products from pharmacies as a precautionary measure due to possible contamination with an impurity N-nitrosodimethylamine (NDMA) which has genotoxic and carcinogenic potential.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code Product Description Livery Affected Batch
6838536 RANITIDINE SF SOLN 150MG/5ML Creo Pharma (Zentiva) ALL STOCK
ALLIANCE DO NOT STOCK RANITIDINE TAB 150MG Tillomed Laboratories ALL STOCK
ALLIANCE DO NOT STOCK RANITIDINE TAB 150MG Tillomed Laboratories ALL STOCK
ALLIANCE DO NOT STOCK RANITIDINE TAB 150MG Tillomed Laboratories ALL STOCK

Creo Pharma Limited

For stock control enquiries please contact Zentiva customer service team on +44 (0) 844 8793 188 or GFD-CUSTOMERSERVICES@zentiva.com

For medical information enquiries please contact Zentiva medical information team on +44 (0) 800 090 2408 or UKMedInfo@zentiva.com

Tillomed Laboratories Limited

For enquiries please email Tillomed on qa@tillomed.co.uk

 

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.